71 Capital Corp. Clarifies Previous News Release

/NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES/

(TSXV: SVN.P)

TORONTO, Nov. 2 /CNW/ - 71 Capital Corp. (the "Corporation") (TSXV: SVN.P) has issued this release to clarify a statement made in its press release dated October 28, 2010 regarding its proposed qualifying transaction with Orx Pharmaceutical Corporation ("Orx"). 

In its previous release the Corporation indicated that Orx would be acquiring "an intellectual property portfolio that includes issued or pending patents for four (4) new pharmaceutical formulations involving certain existing drugs together with all intellectual property rights associated with or relating to the existing clinical development regarding these new pharmaceutical formulations.".  This statements should have provided as follows that Orx would be acquiring  "the intellectual property rights necessary to commercialize in Canada and the United States four (4) new pharmaceutical formulations involving certain existing drugs."

All other aspects of the October 28, 2010 release remain correct.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

Cautionary Statements

This news release contains "forward-looking statements" within the meaning of applicable securities laws relating to the proposal to complete the Qualifying Transaction and associated transactions, including statements regarding the terms and conditions of the Qualifying Transaction and associated transactions.  Readers are cautioned not to place undue reliance on forward-looking statements. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, the risks that the parties will not proceed with the Qualifying Transaction and associated transactions, that the ultimate terms of the Qualifying Transaction and associated transactions will differ from those that currently are contemplated, and that the Qualifying Transaction and associated transactions will not be successfully completed for any reason (including the failure to obtain the required approvals or clearances from regulatory authorities). The statements in this news release are made as of the date of this release. The Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation, Orx, or their respective financial or operating results or (as applicable), their securities.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

71 CAPITAL CORP.
ERIC ROBLIN
PHONE NO: [phone]